Announcements Trials

Browse Landscape

Phase

Status

Recruiting 4 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1 CNS 1

Conditions

Pheochromocytoma 1 Paraganglioma 1

Interventions

pembrolizumab 374 Carboplatin 276 Specimen Handling 265 Nivolumab 252 Magnetic Resonance Spectroscopy 244 Cyclophosphamide 240 Cisplatin 213 Paclitaxel 206 Radiotherapy 195 Biopsy 171 Gemcitabine 155 Dexamethasone 148 durvalumab 143 atezolizumab 126 Rituximab 120 Doxorubicin 115 Bevacizumab 114 Lenalidomide 113 Ipilimumab 111 Radiation 109 Docetaxel 103 Pemetrexed 102 Etoposide 101 fludarabine 97 venetoclax 95 Fluorouracil 92 Capecitabine 92 Radiosurgery 90 Prednisone 89 Oxaliplatin 89

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × lanreotide × 1 year × Clear all

NCT03946527 2026-03-02

LAMPARA

Columbia University

Phase 2 Active not recruiting

Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡